title: More robust evidence for the efficacy of lithium in the long-term treatment of bipolar disorder: should lithium (again) be recommended as the single preferred first-line treatment?
abstract: With two recent systematic reviews and meta-analyses on the efficacy of lithium compared to placebo and other treatment options, it can now be concluded that lithium is the only drug that has been shown efficacious in the prevention of any mood episodes, manic episodes and depressive episodes in randomised trials not enriched for prior response to and tolerance of lithium. It is argued that lithium should be recommended as the single preferred first-line drug in the long-term treatment of bipolar disorder.
authors: Department of Psychiatry, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
authors: Willem A
authors: WA
authors: Nolen
keywords: Bipolar disorder; Guideline; Lithium; Long-term treatment
references: Bipolar Disord. 2013 Feb;15(1):1-44
references: 23237061
references: Am J Psychiatry. 2004 Feb;161(2):217-22
references: 14754766
references: J Clin Psychiatry. 2011 Nov;72(11):1452-64
references: 22054050
references: World J Biol Psychiatry. 2013 Apr;14(3):154-219
references: 23480132
references: Lancet. 2009 Aug 22;374(9690):620-7
references: 19595447
references: Lancet Psychiatry. 2014 Oct;1(5):351-9
references: 26360999
references: Am J Psychiatry. 2002 Apr;159(4 Suppl):1-50
references: 11958165
references: Psychother Psychosom. 2006;75(5):265-9
references: 16899962
references: Int J Bipolar Disord. 2014 Dec 20;2:15
references: 25530932